Clinical Trials in Seattle

Showing 801-820 of 8,049 trials

Pain Relief With Integrative Medicine (PRIMe)?: Feasibility of Acupuncture for Long COVID

NCT06476496

The goal of this preliminary study is to test methods and procedures to be used in a fully-powered trial to evaluate acupuncture treatment effectiveness. Specifically, we will test the feasibility of conducting a 2-arm randomized clinical trial for evaluating the effectiveness of acupuncture for pain in patients with long COVID. Researchers will compare pain intensity and impact on general activities over 5 months in those who receive acupuncture treatment compared to patients who are receiving usual long COVID care. Participants will complete 4 online surveys at weeks 0, 4, 8, and 20. These surveys include validated mental and physical health questionnaires. Participants who are randomly selected to receive the intervention will receive 8 acupuncture treatment sessions.

Long COVIDPain

University of Washington82 participantsStarted Jun 2024

Seattle, Washington, United States

RECRUITINGPhase 1/2< 1 mile

SMP-3124LP in Adults With Advanced Solid Tumors

NCT06526819

An Open-label, Phase I Dose Escalation and Phase 2 Dose Expansion Study to Assess Safety, Tolerability, Preliminary Antitumor Activity of SMP 3124LP in Adults with Advanced Solid Tumors

Solid Tumor

Sumitomo Pharma America, Inc.120 participantsStarted Aug 2024

Los Angeles, California, United States • Denver, Colorado, United States • Chicago, Illinois, United States +7 more locations

Pain Relief With Integrative Medicine (PRIMe)?: Feasibility of Acupuncture for Long COVID

SMP-3124LP in Adults With Advanced Solid Tumors

Find Trials by Condition in Seattle

Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors

Oral N-acetylcysteine for Retinitis Pigmentosa

Sacituzumab Govitecan Before Radical Cystectomy for the Treatment of Non-Urothelial Muscle Invasive Bladder Cancer

Use of CereGate Therapy for Freezing of Gait in PD

Addressing Barriers to Care for Substance Use Disorder Trial

Mobile Health and Social Media Physical Activity Intervention Among Adolescent and Young Adult Childhood Cancer Survivors, the StepByStep Study

Starlight Cardiovascular Lifeline Ductus Arteriosus Stent IDE Study

Sparsentan in Posttransplant Immunoglobulin A Nephropathy or Focal Segmental Glomerulosclerosis

Clinical Trial Navigation to Increase Participation and Diversity in Cancer Clinical Trials

A Study of TAK-788 in Adults With Non-Small Cell Lung Cancer

Study to Assess the Effect of Ofatumumab in Treatment Naïve, Very Early RRMS Patients Benchmarked Against Healthy Controls.

A Study of Tepotinib Plus Osimertinib in Osimertinib Relapsed MET Amplified NSCLC (INSIGHT 2)

Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations

Optimized Predictive Treatment In Medications for Unipolar Major Depression (OPTIMUM-D)

Primary Tumor Research and Outcomes Network

The RESET Clinical Trial: SPRINT® Peripheral Nerve Stimulation for the Treatment of Back Pain

Safety and Preliminary Effectiveness of BNT327, an Investigational Therapy for Breast Cancer, When Given in Combination With Chemotherapy

Research Study Looking at How Well Semaglutide Tablets Taken Once Daily Work in People Who Have a Body Weight Above the Healthy Range